Cordyceps Sunshine Biotech Holdings Co., Ltd. (RAJAF)
OTCMKTS · Delayed Price · Currency is USD
9.18
+0.62 (7.24%)
At close: Jul 9, 2025

RAJAF Revenue

In the year 2024, Cordyceps Sunshine Biotech Holdings had annual revenue of $1.25M with 42.03% growth. Cordyceps Sunshine Biotech Holdings had revenue of $315.50K in the quarter ending December 31, 2023, with 210.58% growth.

Revenue
1.25M
Revenue Growth
+204.16%
P/S Ratio
813.80
Revenue / Employee
96.42K
Employees
13
Market Cap
1.02B

Revenue Chart

Revenue History

Fiscal Year EndRevenueChangeGrowth
Dec 31, 20241.25M370.95K42.03%
Dec 31, 2023882.53K829.23K1,555.66%
Dec 31, 202253.30K--
Dec 31, 2021---
Dec 31, 2020202.08K--

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition